BP PLC
12 July 2001
CINVEN TO BUY BURMAH CASTROL'S Metallurgical
Chemicals and Releasants Divisions
BP announced today that it has reached agreement with Cinven, one of Europe's
leading private equity firms, for the sale of a number of Burmah Castrol's
speciality chemicals businesses. The businesses will be purchased from Burmah
Castrol plc for £204 million, to be satisfied in cash and the assumption of
debt, and held by a newly established company funded by Cinven.
The businesses to be sold include: Foseco, which provides products and
services to the foundry and steel industries; Foseco's stake in Fosbel, a
joint venture company which provides services to operators of coke, glass and
other furnaces; Chem-Trend, a manufacturer of specialised mould and die-cast
release agents; and Remet, which supplies products to the casting industry.
Subject to regulatory and other approvals, the parties expect to complete the
transaction in the third quarter of 2001.
In March 2000, when BP announced its intention to buy Burmah Castrol, the
company also said it intended to dispose of Burmah Castrol's speciality
chemicals businesses. Today's announcement marks a significant step in that
process.
BP is being advised by Credit Suisse First Boston with regard to the sale.
Further enquiries:
David Nicholas, BP Press Office, London: - +44 (0)20 7496 4708
- ENDS -
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.